Edition:
United Kingdom

People: Lannett Company Inc (LCI.N)

LCI.N on New York Stock Exchange

5.88USD
5:22pm BST
Change (% chg)

$0.20 (+3.52%)
Prev Close
$5.68
Open
$5.69
Day's High
$5.98
Day's Low
$5.67
Volume
70,071
Avg. Vol
278,086
52-wk High
$14.65
52-wk Low
$3.34

Cavanaugh, Maureen 

Ms. Maureen M. Cavanaugh is the Senior Vice President and Chief Commercial Operations Officer of the Company. For the last 11 years, Cavanaugh worked for Teva PharmaceuticalsUSA, most recently as senior vice president, chief commercial officer, North America Generics, where she had oversight responsibility for leading trade sales, new product planning and portfolio management teams, as well as the long range planning and strategy development processes for the company's U.S. generics business. Earlier at Teva, she was general manager, U.S. generics with responsibility for sales and marketing and, before that, held a variety of positions in marketing and customer operations. Cavanaugh previously served as senior director, marketing for PAR Pharmaceuticals; and, director, product management and market research for Sandoz (the generic drug division of Novartis). Prior to that, she held a number of finance, sales and marketing operations positions at Bristol Myers-Squibb.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick LePore

129,785

Timothy Crew

1,329,780

Martin Galvan

763,745

John Abt

565,013

Maureen Cavanaugh

--

Grant Brock

--
As Of  30 Jun 2018